Appendicitis Market Size & Share, by End-user (Hospitals & Clinics, Diagnostic Centers); Type (Acute, Chronic); Diagnosis; Treatment - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 6915
  • Published Date: Jan 06, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Appendicitis Market size was over USD 7.9 billion in 2024 and is estimated to reach USD 13.2 billion by the end of 2037, expanding at a CAGR of 4.4 % during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of the appendicitis is assessed at USD 8.2 billion.

The rising number of appendicitis cases is significantly influenced by lifestyle changes, including poor dietary habits, such as the increased consumption of processed and low-fiber foods, and sedentary lifestyles. For instance, an estimated 300,000 hospital visits for appendicitis are reported each year in the U.S., according to a report published in February 2024 by the National Library of Medicine.  Rapid urbanization, particularly in developing economies, is exacerbating these trends by promoting unhealthy eating habits and reduced physical activity. As a result, the incidence of appendicitis is increasing, driving a higher demand for timely medical interventions and treatments. 

Additionally, the adoption of cutting-edge diagnostics tools, including CT scans, MRI, and ultrasound, has revolutionized the detection of appendicitis. These technologies enable quicker and more accurate diagnosis, allowing healthcare providers to identify the condition at earlier stages. Early and precise detection not only helps reduce complications but also supports timely interventions, which are essential for preventing severe outcomes. As a result, there is an increasing demand for appendicitis treatment services across healthcare settings. Thus propelling the market.


Get more information on this report: Request Free Sample PDF

Appendicitis Sector: Growth Drivers and Challenges

Growth Drivers

  • Surgical advancements coupled with aging populations: The rise of laparoscopic appendectomy and other minimally invasive procedures has made appendicitis treatment more effective, safer, and less risky. For instance, in 2021 as per the European Commission laparoscopic appendectomy rates were over 90% in France and Denmark. These techniques offer shorter recovery times and fewer complications, encouraging timely medical care. Additionally, the global increase in the elderly population with 1 in 6 people in the world aged 60 years or over by 2030 per WHO in Oct 2024, is contributing to a rise in health complications, including appendicitis. Older individuals are more prone to complications from untreated appendicitis, further driving the demand for timely and effective treatment. Thus, propelling the appendicitis market.

Challenge

  • High Cost of Treatment: The cost of appendicitis treatment, particularly for surgical procedures like laparoscopic appendectomy, can be a significant burden, particularly in low-income regions. The expenses associated with diagnostic tests, hospital stays, anesthesia, and post-surgery care often lead to financial strain for patients and their families. This financial barrier can limit access to timely medical intervention, particularly in areas with limited healthcare infrastructure, exacerbating the risk of complications and affecting overall treatment outcomes. Thus, restricting the appendicitis market.
  • Rising Antibiotic Resistance: Continuous rise in resistance towards antibiotics has become challenging for the treatment of appendicitis with antibiotics alone in cases where surgery is not immediately necessary. Resistant infections complicate the management of appendicitis, making it harder to control infections effectively without surgical intervention. Additionally, the rise in antibiotic resistance can complicate post-surgery recovery, increasing the risk of infections and other complications, which may prolong hospital stays and lead to a higher likelihood of adverse outcomes. Overall limiting the appendicitis market.

Appendicitis Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

4.4%

Base Year Market Size (2024)

USD 7.9 billion

Forecast Year Market Size (2037)

USD 13.2 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Appendicitis Segmentation

End user (Hospitals & Clinics, Diagnostic Centers)

The hospital & clinics segment is predicted to capture around 73.4% appendicitis market share by the end of 2037. The segment’s growth is due to its critical role in providing comprehensive appendicitis treatment, including diagnosis, surgery, and post-operative care. These healthcare facilities are equipped with advanced diagnostic tools, surgical capabilities, and highly trained medical professionals, ensuring timely trained medical professionals, ensuring timely and effective management of appendicitis. Additionally, hospitals and clinics are more accessible, especially in urban areas, contributing to their dominance in the market.

Type (Acute, Chronic)

By type, the acute segment is slated to capture the largest market share over the forecast period. The segment’s growth is owing to the increasing number of patients presenting with severe symptoms that require urgent medical intervention. The incidence rate of acute appendicitis ranges from 100 to 223 new cases per 100,000 people annually. Acute appendicitis often leads to rapid deterioration if not treated promptly, making it a priority for healthcare providers. Early diagnosis and timely surgical intervention, such as laparoscopic appendectomy, are critical to prevent complications like rupture or infection, driving the growth of the acute appendicitis treatment segment, and propagating the market.

Our in-depth analysis of the global market includes the following segments:

Type

  • Acute
  • Chronic

End user

  • Hospitals & Clinics
  • Diagnostic Centers

Diagnosis

  • Ultra Sound Imaging
  • Ct scan
  • Others

Treatment

  • Medication
  • Surgery
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Appendicitis Industry - Regional Synopsis

North America Market Statistics

North America in appendicitis market is set to dominate over 49.2% revenue share by 2037. The incidence of appendicitis is rising in North America, increasing the demand for effective treatments. According to estimates, there are about 29 instances of perforated appendicitis for every 100,000 person-years in the United States (US). The lifetime risk of appendicitis is 8.6% for males and 6.7% for females. This growing prevalence underscores the need for advanced medical interventions to manage and treat appendicitis effectively. Robust healthcare systems and government support in North America facilitate access to advanced surgical treatments and promote the adoption of innovative medical technologies, contributing to appendicitis market growth.

The U.S. healthcare system capacity to adopt advanced surgical instruments and medications supports the expansion of appendicitis treatments. This capability enables healthcare providers to implement cutting-edge technologies and therapies, enhancing patient outcomes and streamlining surgical procedures. Consequently, the integration of these innovations contributes to the growth and development of appendicitis treatment options across the country. The development of laparoscopic and robotic-assisted appendectomies has improved patient outcomes, reduced recovery times, and increased the adoption of these procedures, thus propelling the market.

In Canada, the appendicitis market is poised to garner lucrative market share over the forecast period. The increasing incidence of appendicitis in Canada has led to greater need for effective and timely treatment options. This demand is driving market growth, as healthcare providers seek advanced surgical techniques and improved medical therapies to manage the rising number of cases. Consequently, there is a significant opportunity for innovation and investment in appendicitis treatment solutions within the Canada healthcare system.

Asia Pacific Market Analysis

The Asia Pacific appendicitis market is established to garner the fastest CAGR through the forecast period. The rising incidence of appendicitis is significantly influenced by changes in dietary habits, such as increased consumption of processed and how fiber foods, coupled with sedentary lifestyles. As per the Institute for Health Metrics and Evaluation in July 2024 the global appendicitis incidence in 2021 was 214/100,000, the highest in Asia Pacific (364/100,000). Rapid urbanization and lifestyle transitions in developing economies further contribute to this growing health concern. Asia Pacific governments are enhancing healthcare access through supportive policies while growing insurance coverage makes surgeries more affordable.

The appendicitis market is projected to grow in China owing to advancements in medical technology. The healthcare system rapidly adopting modern diagnostics and treatment technologies, including laparoscopic surgery and high-resolution imaging. In September 2024, BioMed Central Ltd. reported that more than 10 million laparoscopic procedures were carried out in China per year.  These advancements improve diagnostic accuracy, reduce recovery times, and enhance overall treatment outcomes, boosting patient confidence. The aging population in China increases appendicitis-related complications, with older individuals seeking timely care, driving appendicitis market growth.

India is emerging as a hub for medical tourism, offering high-quality and cost-effective appendicitis treatment. The India Brand Equity Foundation estimates that the country's medical tourism operations will grow from its 2024 valuation of USD 7.6 billion to USD 14.3 billion by 2029. International patients seeking affordable surgical procedures further boost the appendicitis market. The adoption of advanced diagnostic tools, including high-resolution ultrasound and CT scans, coupled with minimally invasive laparoscopic surgeries, has significantly enhanced treatment accuracy, reduced recovery times, and minimized complications, encouraging more patients to seek timely medical interventions.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Appendicitis Landscape

    Key companies dominate the appendicitis market through advanced diagnostic technologies, minimally invasive surgical solutions, and robust global distribution networks. They invest heavily in R&D to develop innovative treatments, improving patient outcomes and reducing recovery times. In April 2024, Medtronic launched AI algorithms for post-operative analysis and Touch Surgery Live stream, enhancing laparoscopic and robotic surgery with AI-driven insights and digital technologies.  Strategic collaborations with healthcare providers enhance accessibility, while targeted marketing campaigns raise awareness. These companies leverage economies of scale, regulatory expertise, and premium healthcare services to maintain market leadership and capture significant segment shares across regions.

    • Pfizer Inc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Lupin
    • Siemens
    • Koninklijke Philips NV
    • Becton, Dickinson and Company
    • Braun Melsungen AG
    • Cook
    • Medtronic
    • Teva Pharmaceutical Industries Ltd

In the News

  • In October 2024, Olympus announced that Odin Medical’s cloud-AI endoscopy devices-CADDIE, CADU, and SMARTBD- have received CE marking in Europe, enhancing clinical outcomes and operational efficiency in endoscopy.
  • In August 2024, Terumo India launched the TREO Stent-Graft System for Endovascular Aneurysm Repair (EVAR), designed for infrarenal abdominal aortic aneurysms with unique suprarenal and infrarenal active fixation.

Author Credits:  Radhika Pawar


  • Report ID: 6915
  • Published Date: Jan 06, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the appendicitis market was over USD 7.9 billion.

The market size for the appendicitis market is projected to reach USD 13.2 billion by the end of 2037 expanding at a CAGR of 4.4% during the forecast period i.e., between 2025-2037.

The major players in the market are Lupin, Siemens, Koninklijke Philips NV, Becton, Dickinson and Company, and others.

In terms of type segment, the acute segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 49.2% by the end of 2037 and provide more business opportunities in the future.
Appendicitis Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample